Curaleaf Holdings, Inc. (TSX: CURA; OTCQX: CURLF), a globally prominent provider of cannabis consumer products, today confirmed its selection for entry into Canada’s premier equity benchmark—the S&P/TSX Composite Index.
A Landmark Inclusion
With its addition to the index under the Health Care sector, Curaleaf joins the ranks of the most highly capitalized and actively traded companies on the Toronto Stock Exchange, gaining heightened visibility across North American financial markets. Notably, it stands as the first U.S.-based cannabis operator to be admitted to this benchmark, a watershed moment for the industry.
Executive Commentary
Boris Jordan, Chairman and Chief Executive Officer of Curaleaf, underscored the significance of this development:
“This marks a pivotal moment for Curaleaf and represents a significant moment for mainstream normalization across the broader cannabis industry. … Our inclusion reflects an expanded presence in public markets and broadens our access to institutional investment and index‑linked vehicles…”
This recognition not only affirms Curaleaf’s corporate stature but also signals a broader shift in the legitimization of cannabis enterprises within mainstream capital markets.
Industry Impact
Inclusion in a major index typically enhances a company’s credibility and often attracts institutional and passive investment flows through index‑tracking funds and ETFs. Curaleaf’s presence in the S&P/TSX Composite Index may pave the way for broader investor access and more robust valuation dynamics.
Summary at a Glance
| Event | Details |
|---|---|
| Company | Curaleaf Holdings, Inc. (TSX: CURA; OTCQX: CURLF) |
| Index | S&P/TSX Composite Index (Health Care sector) |
| Effective Date | Prior to trading on Monday, September 22, 2025 |
| Significance | First U.S. cannabis company in this Canadian benchmark index |
| Implications | Greater visibility, institutional access, enhanced industry stature |
Dabbin-Dad Newsroom
